No Data
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
CT Enterprise (03839.HK) reported a profit of 5.605 million US dollars in the first three quarters.
The ct enterprise issued an announcement on November 12, stating that for the nine months ending on September 30, 2024, the company's revenue was 0.17 billion US dollars, compared to 0.12 billion US dollars in the same period last year; the net profit for the period was 5.605 million US dollars, compared to 2.177 million US dollars in the same period last year.
Express News | Chia Tai Enterprises International Ltd - Nine Months Profit US$5.6 Mln
CT ENTERPRISE: Unaudited Results for the Nine Months Ended 30 September 2024
ct enterprise (03839.HK) will hold a board of directors meeting on November 12 to approve performance.
ct enterprise (03839.HK) announced on October 30 that the board of directors will hold a board meeting on November 12, 2024, to approve the unaudited performance of the company and its subsidiaries for the nine months ended September 30, 2024, as part of it.
Not Many Are Piling Into Chia Tai Enterprises International Limited (HKG:3839) Stock Yet As It Plummets 26%
No Data
